InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by FLETCHER R JOHN, Director. Director active across 5 companies, notably Vyant Bio, Inc.. Cumulatively, 26 reports have been published. Total volume traded: €259k. The latest transaction was filed on 25 May 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations26 total
09,269 shares0
Common Stock
SEC:0001420506-22-001145:0·
3,944 shares
Common Stock, $0.0001 par value
SEC:0001493152-22-010476:0·
24,844 shares
Common Stock, $0.0001 par value
SEC:0001493152-22-009831:0·
€15,6611,741 shares@ €8.99540.0038% mcap12.8% of flow
Common Stock
SEC:0001171520-22-000233:0·
€20,3017,832 shares@ €2.5920.0075% mcap8.1% of flow
Common Stock
SEC:0001161697-22-000159:0·
43,478 shares
Common Stock, $0.0001 par value
SEC:0001493152-22-008834:0·
€4,2723,721 shares@ €1.14819.5% of flow
Common Stock, $0.0001 par value
SEC:0001493152-22-001790·
€4,2723,721 shares@ €1.14814.7% of flow
Common Stock, $0.0001 par value
SEC:0001493152-22-001790:0·
€20,4102,003 shares@ €10.18980.0050% mcap38.1% of flow
Common Stock
SEC:0001171520-22-000013·
€20,4102,003 shares@ €10.18980.0050% mcap16.6% of flow
Common Stock
SEC:0001171520-22-000013:0·
€19,8687,500 shares@ €2.6490.011% mcap36.8% of flow
Common Stock
SEC:0001161697-22-000010·
€19,8687,500 shares@ €2.6490.0074% mcap7.9% of flow
Common Stock
SEC:0001161697-22-000010:0·
€19,4387,894 shares@ €2.46230.011% mcap36.0% of flow
Common Stock
SEC:0001161697-21-000468·
€19,9721,290 shares@ €15.48230.0049% mcap37.3% of flow
Common Stock
SEC:0001420506-21-001362·
€19,4387,894 shares@ €2.46230.0072% mcap7.7% of flow
Common Stock
SEC:0001161697-21-000468:0·
€19,9721,290 shares@ €15.48230.0049% mcap16.3% of flow
Common Stock
SEC:0001420506-21-001362:0·
€14,6203,744 shares@ €3.90490.0082% mcap27.1% of flow
Common Stock
SEC:0001161697-21-000328·
€14,6203,744 shares@ €3.90490.0054% mcap5.8% of flow
Common Stock
SEC:0001161697-21-000328:0·
€13,174771 shares@ €17.08730.0032% mcap24.6% of flow
Common Stock
SEC:0001420506-21-000843·
€13,174771 shares@ €17.08730.0032% mcap10.7% of flow
Common Stock
SEC:0001420506-21-000843:0·
03,003 shares0
Common Stock
SEC:0001171520-21-000262·
03,003 shares0
Common Stock
SEC:0001171520-21-000262:0·
€40,85615,000 shares@ €2.723890.5% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-012688·
Ideal exit: 15 Feb 2022 (T+270)
€40,85615,000 shares@ €2.723845.3% of flow
Common Stock, $0.0001 par value
SEC:0001493152-21-012688:0·
Ideal exit: 15 Feb 2022 (T+270)
€88,42725,000 shares@ €3.5371100.0% of flow
Common Stock
SEC:0001161697-21-000267·
Ideal exit: 11 Feb 2022 (T+270)
25 of 26 declarations
About FLETCHER R JOHN
Fletcher R John is an executive at Repro Med Systems Inc.
